When the 2003 Medicare Modernization Act was passed, pharmaceutical industry lobbyists pulled off an incredible stunt. That law saw to it that taxpayers no longer paid the lowest government-negotiated drug prices for people eligible for both Medicare and Medicaid. When the law took effect in 2006, the government no longer received discounts on drugs for low-income seniors and disabled folks, but instead paid higher Medicare Part D prices. The Medicare Drug Savings Act-Senate Bill S740, House Bill HR1588-introduced by Sen. Jay Rockefeller (D-WV) and Rep. Henry Waxman (D-CA) proposes to reduce Medicare Part D drug costs by simply reverting back to the previous law which required drug companies to pay rebates for all low-income Medicare beneficiaries, saving taxpayers an estimated $141.2 billion over ten years. Studies show on average US drug prices are 50% higher than in other developed nations. This legislation takes a step toward controlling price gouging by the drug industry. It will strengthen Medicare by producing savings without harming beneficiaries. Contact your US Representative and US Senators Baldwin and Johnson to urge them to stand strong for their constituents and against pharmaceutical industry special interests by co-sponsoring the Medicare Drug Savings Act.